Amiloidosis intestinal en paciente con infección por VIH

Segoviano-Mateo, Rocío; Rojano-Martín, Beatriz; Díaz-Ley, Blanca; Sicilia-Enríquez de Salamanca, Juan José.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 23(10): 633-633, dic. 2005.
Artículo en Es | IBECS (España) | ID: ibc-043421

Documentos relacionados

  1. ß-Lactam Resistance Gene NDM-1 in the Aquatic Environment: A Review.
  2. ZN148 Is a Modular Synthetic Metallo-ß-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens <i>In Vivo</i>.
  3. Using Culture-Enriched Phenotypic Metagenomics for Targeted High-Throughput Monitoring of the Clinically Important Fraction of the ß-Lactam Resistome.
  4. A Multispecies Cluster of VIM-1 Carbapenemase-Producing <i>Enterobacterales</i> Linked by a Novel, Highly Conjugative, and Broad-Host-Range IncA Plasmid Forebodes the Reemergence of VIM-1.
  5. What are extended-spectrum beta-lactamases?
  6. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis.
  7. Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship.
  8. Recurrent emergence of <i>Klebsiella pneumoniae</i> carbapenem resistance mediated by an inhibitory <i>ompK36</i> mRNA secondary structure.
  9. First isolation of carbapenem-resistant Acinetobacter beijerinckii from an environmental sample.
  10. Carbapenem resistance in Acinetobacter baumannii is associated with enhanced survival on hospital fabrics.